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Abstract Endogenous ceramide (CER) was generated by
treatment of cultured fibroblasts with sphingomyelinase (SMase)
from Bacillus cereus. A 30 min treatment with 0.1^0.3 U/ml
SMase induced a dose-dependent increase in the intracellular
level of CER. The activation of the transcription factors signal
transducer and activator of transcription (STAT) 1 and STAT3
by SMase was investigated by determination of the phosphor-
ylation state by immunoblot, and of DNA binding activity by
electrophoretic mobility shift assay. SMase treatment induced a
dose-dependent Tyr-phosphorylation of STAT1/3. SMase also
enhanced STAT1/3 DNA binding activity in a dose-dependent
manner. Concomitantly, SMase enhanced the Tyr-phosphoryla-
tion of Janus kinase (JAK) 2, a Tyr-kinase localized upstream of
STATs in the JAK/STAT pathway. The Tyr-kinase inhibitor
genistein and the JAK inhibitor AG490 both prevented JAK2
Tyr-phosphorylation, together with STAT1 and STAT3 Tyr-
phosphorylation and binding activity. The SMase-induced
increase in STAT1/3 binding activity was prevented by methyl-
L-cyclodextrin, a cholesterol binding agent that causes a loss of
compartmentalization of the molecules located in caveolae. This
increase was also prevented by the MEK inhibitor PD98059, thus
demonstrating the role of the MEK/ERK pathway in this system.
Besides ERK, SMase activated other signaling kinases such as
JNK and p38. Exogenous natural CER also activated STAT1/3
binding activity, which indicates that most probably, endogenous
CER is the second messenger involved in the effect of SMase.
These results describe a crosstalk between the SMase/CER and
the JAK/STAT signaling pathways and include JAK2 within the
range of CER-activated intracellular kinases. ß 2001 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
STATs (signal transducers and activators of transcription)
are involved in cytokine, growth factor and hormone trans-
duction pathways (review in [1]). Cytokine binding, after di-
merization/oligomerization of the receptors, initiates the Tyr-
phosphorylation of the receptor-associated Tyr-kinases of the
Janus kinase family (JAKs). Activated JAKs then induce the
Tyr-phosphorylation of the receptor itself and of cytoplasmic
STATs recruited by their SH2 domain [2,3]. Tyr-phosphory-
lated STATs then undergo homo/heterodimerization [4], a
prerequisite for translocation to the nucleus [5]. The Tyr-phos-
phorylated STATs subsequently bind to speci¢c DNA sequen-
ces and exert their transcriptional activity on target genes [6].
We previously demonstrated that STAT1 and STAT3 are ac-
tivated by oxidative stresses generated by oxidized low density
lipoproteins [7] or UV-A radiation [8].
Generation of the sphingolipid ceramide (CER) from sphin-
gomyelin (SM) of the cell membrane has been shown to be an
important signaling event involved in cell growth, di¡erentia-
tion and programmed cell death (review in [9]). This pathway
is also activated by cellular stresses, including activation of
tumor necrosis factor K (TNFK) [10] or interleukin 1 (IL1)
[11] receptors, UV radiation [12] or Fas antigen [13]. Down-
stream of SM hydrolysis, it was demonstrated that CER can
stimulate several adenylyl cyclase subtypes [14]. CER can also
activate di¡erent kinds of kinases, including a Ser/Thr kinase
termed CER-activated protein kinase which turns out to be a
proline-directed kinase [15]. Fas receptor ligation or cellular
treatment with synthetic CER results in activation of the small
G proteins Ras, Rac1 and of the stress kinases JNK and p38
[16]. CER generation after TNFK ligand binding also stimu-
lates Raf1, a Ser/Thr kinase located upstream of MEK-
MAPKK [17]. In vitro, CER leads to the activation of a
Ser/Thr phosphatase related to the PP2A family [18].
In the current studies, we demonstrate crosstalk between
the JAK/STAT and the sphingomyelinase (SMase)/CER sig-
naling pathways in that endogenous CER can activate JAK2,
and thus STAT1 and STAT3, by Tyr-phosphorylation. In
addition, besides JAK2, it appeared that this activation also
involves the MEK pathway. Finally, exogenous natural CER
also activates STAT1/3 DNA binding activity.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM) and fetal calf serum
were from Gibco. The oligonucleotide probes STAT1 (5P-CAT GTT
ATG CAT ATT CCT GTA AGT G-3P) and STAT3 (5P-GAT CCT
TCT GGG AAT TCC TAG ATC-3P) were synthesized by Eurogen-
tec, Belgium. [9,10-3H]Palmitic acid 50 Ci/mmol was provided by
Amersham. [Q-32P]ATP 7000 Ci/mmol was from ICN. The anti-
STAT1 S21120 and anti-STAT3 S21320 antibodies were from Trans-
duction Laboratories. The anti-phosphotyrosine 4G10 and anti-JAK2
antibodies were obtained from Upstate Biotechnology. The JAK in-
hibitor AG490 and the MEK inhibitor PD98059 were from France
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Biochem. SMase from Bacillus cereus, CER from bovine brain and all
other chemicals were of Sigma grade.
2.2. Cell culture
MRC5 human ¢broblasts were purchased from BioMe¤rieux,
France. The cells were maintained in DMEM supplemented with
10% fetal calf serum. All experiments were performed on subcon£uent
cultures, 3 days after seeding. The cells were preincubated for 24 h in
medium devoid of serum and supplemented with 0.1% bovine serum
albumin. It was checked that the preincubation with albumin down-
regulated the studied transduction pathway. The cells were then in-
cubated with 0.1^0.3 U/ml SMase for 30 min before the preparation
of cellular extracts for immunoblot analysis or nuclear extracts for
electromobility shift assay. Natural CER was dissolved in ethanol/
dodecane 98/2 (v/v) according to Ji et al. [19] before addition to the
medium for 1 h. The ¢nal concentrations of ethanol and dodecane
were 0.5% and 0.01% respectively.
2.3. Generation of endogenous ceramide
Cells were incubated overnight with 0.5 WCi/ml palmitic acid. After
washing, the cells were incubated for 30 min with 0.1^0.3 U/ml
SMase. After harvesting, lipid extraction was performed by the meth-
od of Bligh and Dyer [20]. CER and SM were then separated by thin
layer chromatography using chloroform/methanol/H2O 65/25/4 v/v
and petroleum ether/diethyl ether/acetic acid 80/20/1 v/v as solvent
[21]. After visualization in iodine vapor and identi¢cation by known
standards, the radioactivity of the CER spot was determined by liquid
scintillation counting. Results are expressed as dpm CER/Wg protein.
2.4. Immunoprecipitation and immunoblot analysis
Cells were lysed in 20 mM Tris pH 7.9, 400 mM NaCl, 1 mM
EDTA, 20% glycerol, 1 mM dithiothreitol (DTT), 1 mM phenylmeth-
ylsulfonyl £uoride (PMSF), 5 Wg/ml leupeptin and aprotinin and 0.1
mM Na3VO4, and clari¢ed by centrifugation. Immunoprecipitation
was performed on 150 Wg protein with 1.5 Wg of the anti-phosphotyr-
osine antibody 4G10 and 5 mg protein A-Sepharose at 4‡C overnight.
Immunoprecipitates were solubilized and analyzed by SDS^PAGE.
After transfer of proteins onto a nitrocellulose membrane, blots
were revealed with anti-JAK2, anti-STAT1 and anti-STAT3 antibod-
ies. Visualization was performed with the enhanced chemilumines-
cence kit from Amersham.
2.5. Preparation of nuclear extracts
Nuclear extracts were prepared according to Dignam et al. [22].
Cells were resuspended in 10 mM HEPES, 1.5 mM MgCl2, 10 mM
KCl, 0.5 mM DTT, 0.1% Nonidet P-40 and the protease inhibitors
PMSF 0.2 mM, aprotinin 2 mM, antipain, pepstatin, benzamidine
and leupeptin 1 Wg/ml. After homogenization with a Dounce homog-
enizer and a 10 min incubation at 4‡C, nuclei were collected by cen-
trifugation at 2000Ug for 30 min. The pellet was resuspended in 20
mM HEPES pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT, 25% glycerol and the above cited antiproteases. The
nuclear proteins were extracted by incubation at 4‡C during 30 min.
After centrifugation at 13 000Ug for 15 min, the supernatant was kept
at 380‡C.
2.6. Electrophoretic mobility shift assay
The double-stranded oligonucleotides were end-labeled using T4
kinase and [Q-32P]ATP. 7 Wg of nuclear extract was incubated with
100 000 dpm of labeled probe (0.5 ng) in the presence of 1 Wg of
poly(dIdC) at room temperature for 20 min, followed by separation
of the mixture on a 6% non-denaturing polyacrylamide gel in Tris 50
mM/glycine 0.38 M/EDTA 2 mM bu¡er at pH 7.5.
Each experiment was repeated three times. Protein bands and DNA
complexes were quanti¢ed using a Molecular Dynamics densitometer.
The coe⁄cient of analytical variability did not exceed 10^15%.
3. Results
3.1. Generation of endogenous CER by SMase
We ¢rst checked that the treatment of intact cells with
neutral SMase e¡ectively induced the production of CER.
The data in Fig. 1 show that, with tritiated palmitic acid as
precursor, a 30 min incubation with 0.1^0.3 U/ml SMase in-
creased the production of CER in a dose-dependent manner.
An about eight-fold increase was found for 0.3 U/ml SMase.
3.2. SMase enhances STAT1 and STAT3 Tyr-phosphorylation
and binding activity in a dose-dependent manner
The next experiment was designed to investigate the dose-
dependent e¡ect of a 30 min treatment with SMase. Studies of
the Tyr-phosphorylation state by immunoblot indicate that
SMase dose-dependently increased the phosphorylation of
both STATs (Fig. 2A) with a somewhat more marked e¡ect
for STAT1. Concomitantly, SMase also augmented the bind-
ing activity of both STATs in a dose-dependent manner (Fig.
2B).
3.3. SMase activates STATs by means of JAK2
In the cytokine transduction pathway, the Tyr-phosphory-
lation of STATs is under the control of the JAK family [1].
We thus looked upstream of STATs for the activation of
JAK2, a ubiquitous kinase of the JAK family. The results
in Fig. 2C demonstrate ¢rst, that SMase induced the Tyr-
phosphorylation of JAK2, and second, that if the phosphor-
ylation of JAK2 was prevented by genistein or AG490, the
Tyr-phosphorylation of STATs was no longer observed. In
parallel, as expected, the STAT1 and STAT3 binding activ-
Fig. 1. SMase induces the generation of endogenous CER. MRC5
¢broblasts were preincubated overnight with 0.5 WCi/ml palmitic
acid in medium supplemented with 0.1% bovine serum albumin.
After washing, the cells were incubated for 30 min with 0.1^0.3 U/
ml SMase. After harvesting, lipid extraction was performed and the
lipid extract analyzed by thin layer chromatography. Results are ex-
pressed in dpm CER/Wg protein. Means þ S.D. from a typical ex-
periment in triplicate. This experiment was repeated three times
with similar results.
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ities were no longer stimulated (Fig. 2D). Genistein and
AG490 had no e¡ect when added alone (data not shown).
3.4. The caveola inhibitor methyl-L-cyclodextrin prevents the
SMase-induced STAT1 and STAT3 activation
Since SM is localized within caveolae [23], which are plasma
membrane domains enriched in cholesterol, the next experi-
ment was designed to test the e¡ect of the cholesterol binding
agent methyl-L-cyclodextrin, which has been reported to cause
the loss of compartmentalization of molecules located in cav-
eolae [24]. It was noted (Fig. 3A) that while SMase and meth-
yl-L-cyclodextrin alone exhibited little e¡ect on the cell mor-
phology, the combination of the two factors induced a
marked modi¢cation of the cell shape, indicating some per-
turbation within the membrane architecture. Furthermore,
after treatment with methyl-L-cyclodextrin, the SMase-in-
duced STAT1 and STAT3 activation was no longer observed
(Fig. 3B).
3.5. The activation of STATs by SMase also involves ERK
Since it is known that the Tyr-phosphorylation of STATs is
required for DNA binding, whereas Ser-phosphorylation by
ERK regulates the transactivating potential [25], we also
looked for any e¡ect of SMase on ERK activity. Fig. 4A
demonstrates that 0.2 U/ml SMase markedly activated
ERK. In addition, the MEK inhibitor PD98059, which exhib-
ited no e¡ect by itself (data not shown), prevented the SMase-
induced activation of both STATs (Fig. 4B), thus demonstrat-
ing the role of the MEK/ERK pathway in this phenomenon.
The data from Fig. 4C indicate that besides ERK, SMase also
activated the kinases JNK and p38.
3.6. Exogenous natural CER enhances STAT1/3 binding
activity
A dispersion of exogenous CER was introduced in the cul-
ture medium in ethanol/dodecane solution in order to deliver
hydrophobic CER to cells [19]. It was found (Fig. 5) that 200
Fig. 2. SMase enhances STAT1 and STAT3 tyrosine-phosphorylation (A) and DNA binding activity (B). The CER-induced Tyr-phosphoryla-
tion (C) and binding activity (D) of STAT1 and STAT3 are prevented by genistein and AG490. MRC5 ¢broblasts were preincubated for 24 h
in medium supplemented with 0.1% bovine serum albumin and incubated for 30 min with 0.1^0.3 U/ml SMase. 5U1035 M genistein and
2U1035 M AG490 were added 30 min before a further incubation of 30 min with 0.2 U/ml SMase. Cellular or nuclear extracts were then pre-
pared. STAT1 and STAT3 phosphorylation state was determined by immunoprecipitation (IP) with an anti-TyrP antibody followed by immu-
noblotting (IB) with an anti-STAT1 or -STAT3 antibody. STAT1 and STAT3 DNA binding activities were studied by electrophoretic mobility
shift assay. Results are from a typical experiment. This experiment was repeated three times.
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Fig. 3. E¡ect of SMase and methyl-L-cyclodextrin on cell morphology. The caveola inhibitor methyl-L-cyclodextrin prevents the SMase-induced
STAT1 and STAT3 activation. MRC5 ¢broblasts were preincubated for 24 h in medium supplemented with 0.1% bovine serum albumin and
pretreated for 30 min with 5 mM methyl-L-cyclodextrin. After washing, the cells were incubated with 0.2 U/ml SMase for 30 min. STAT1 and
STAT3 DNA binding activities were studied by electrophoretic mobility shift assay. Results are from a typical experiment. This experiment was
repeated three times.
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nM and 500 nM CER increased STAT1/3 activity in a dose-
dependent manner, thus demonstrating that most probably,
the second messenger CER is involved in the action of SMase.
4. Discussion
We ¢rst demonstrated that the second messenger CER can
be produced by treatment of cultured ¢broblasts with neutral
SMase of bacterial origin (Fig. 1). This is an interesting alter-
native to the utilization of exogenous CER and resolves the
problem of cellular penetration and delivery to intracellular
targets. Indeed, it has been reported that the generation of
CER from SM is highly compartmentalized and takes place
in SM-rich plasma membrane domains with the characteristics
of caveolae [23]. That caveolae are involved in membrane
internalization [26] may thus facilitate the delivery of CER
within the cell and the activation of signaling kinases and
transcription factors. In our experimental conditions, the
fact that methyl-L-cyclodextrin, a cholesterol binding agent
which induces a loss of compartmentalization of the molecules
located within caveolae, prevented the SMase-induced activa-
tion of STAT1 and STAT3 (Fig. 3B) indicates that the gen-
eration of CER most probably takes place in caveolae. In this
regard, it is of note that exogenous natural CER exhibited the
same e¡ect as SMase (Figs. 2B and 5).
Once generated, CER activated STAT1 and STAT3 DNA
binding activity in a dose-dependent manner (Fig. 2B). This
activation is due, as expected, to the Tyr-phosphorylation of
the transcription factors (Fig. 2A). Activation of transcription
factors is a general mechanism whereby CER exerts its action
on cellular proliferation, di¡erentiation and apoptosis. It has
been reported that CER activates AP1 by increasing c-jun
mRNA synthesis [27], or NF-UB by inducing the processing
of p105 to p50, a component of the NF-UB transcription
factor [28]. Exogenous SMase also stimulates NF-UB activity,
an e¡ect inhibited by low temperature or hypertonicity, two
inhibitors of receptor internalization [29]. Concerning the
mechanism of action of CER, it has been proposed that this
second messenger primarily acts by inducing an oxidative
stress, via a hyperproduction of reactive oxygen species by
the mitochondrial electron transport chain [30]. Indeed, C2-
CER directly stimulates the production of hydrogen peroxide
by mitochondrial preparations [30,31]. It has also been re-
ported that the CER-induced activation of NF-UB and AP1
is mediated by mitochondrial-derived reactive oxygen species
[32].
Several lines of evidence indicate that the activation of tran-
Fig. 4. The MEK inhibitor PD98059 prevents the activation of
STAT1 and STAT3 by SMase (A, B). SMase activates JNK and
p38 (C). MRC5 ¢broblasts were preincubated for 24 h in medium
supplemented with 0.1% bovine serum albumin. 1035 M PD98059
was then added 30 min before a further 30 min incubation with 0.2
U/ml SMase. Cellular or nuclear extracts were then prepared. ERK,
JNK and p38 phosphorylation states were determined by immuno-
blot with a speci¢c antibody (A, C). STAT1 and STAT3 DNA
binding activities were studied by electrophoretic mobility shift assay
(B). Results are from a typical experiment. This experiment was re-
peated three times.
Fig. 5. Exogenous natural CER enhances STAT1 and STAT3 bind-
ing activity. MRC5 ¢broblasts were preincubated for 24 h in me-
dium supplemented with 0.1% bovine serum albumin. CER was
then added in ethanol/dodecane 98/2 v/v solution for 1 h. STAT1
and STAT3 DNA binding activities were studied by electrophoretic
mobility shift assay. Results are from a typical experiment. This ex-
periment was repeated three times.
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scription factors by SMase might be achieved by means of its
action on stress-activated kinases. Reunanen et al. [33] re-
ported that the expression of the matrix metalloprotease
MMP1 is under the control of CER via an AP1 cis element,
and that the CER-induced activation involves ERK1/2,
SAPK/JNK and p38. Similarly, Brennen et al. [34] demon-
strated that the activation of the transcription factor GADD
153 by CER results from the stimulation of the small G pro-
tein Rac1 and the kinases JNK and p38. In our experimental
model, the JAK inhibitor AG940 (Fig. 2C,D) and the MEK
inhibitor PD98540 (Fig. 3A,B) both prevented the SMase-in-
duced activation of STAT1/3, which demonstrates that SMase
stimulates not only the Tyr-phosphorylation of STAT1 and
STAT3 by means of JAK2, but also their Ser-phosphorylation
by means of ERK. It is of note that in our experimental
conditions, besides JAK2 and ERK, SMase also induced a
stimulation of other signaling kinases such as JNK and p38
(Fig. 3C).
The current studies point to the pleiotropic nature of CER-
mediated signaling pathways by including JAK2 within the
range of CER-activated intracellular kinases. The stimulation
of JAK2 activity then in turn enhances STAT1 and STAT3
Tyr-phosphorylation and DNA binding activity, which iden-
ti¢es STAT transcription factors as downstream targets of
CER. Previous work from our laboratory demonstrated that
UV-A radiation induces CER production [35], and concom-
itantly enhances STAT1 binding activity [8], which suggests
that physio-pathological stimuli generating endogenous CER
also stimulate the JAK/STAT pathway. Since the SMase/CER
signaling pathway is triggered by some in£ammatory cyto-
kines such as TNFK and IL1, the activation of the JAK/
STAT pathway might provide, besides the other well-known
CER-activated transduction pathways, an additional e⁄cient
mechanism to regulate the in£ammatory response.
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